Results 231 to 240 of about 49,719 (277)

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells. [PDF]

Front Immunol
Korompis M, De Voss CJ, Li S, Ateere A, McShane H, Stylianou E.   +5 more
europepmc   +1 more source

Beyond “you are what you eat”: Unlocking gut microbiota‐mediated biotransformation of dietary phytochemicals

iMetaOmics, Volume 3, Issue 2, June 2026.
The “efficacy paradox” of phytochemicals, low bioavailability yet significant health benefits, is associated with gut microbiota, which biotransforms dietary precursors into bioactive metabolites, enabling systemic effects. Thus, health outcomes of diet depend not just on intake “the rainbow”, but on gut microbial metabolism, redefining “you are what ...
Peng Yang, Ren‐You Gan
wiley   +1 more source

Editorial: Vaccines and molecular therapeutics for tuberculosis. [PDF]

Front Immunol
Sable SB, Velu V, Kupz A.
europepmc   +1 more source

Bacterial Extracellular Vesicles (BEVs) Derived from Chryseobacterium Inhibit Dengue Virus Infection by Disrupting Its Structural Integrity

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
This study elucidates a novel antiviral mechanism of bacterial BEVs, which are shown to inactivate viruses by triggering membrane fusion, subsequent lysis and causing structural collapse. This direct virucidal action presents a promising broad‐spectrum strategy against diverse enveloped viruses.
Yaqi Gao, Lijian Zhang, Tianci Zhang, Qiufeng Yao, Ruifang Gao, Yue Wang, Yunpeng Zhao, Tingting Zhou, Jikuai Chen, Xing Zhang, Hao Ren, Yongzhe Zhu, Ping Zhao, Zhongtian Qi, Li Luo, Zhaoling Qin   +15 more
wiley   +1 more source

Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine. [PDF]

J Nanobiotechnology
Wang X, Luo H, Fan Z, Xie R, Liu S, Pan Q, Zhang Z, Yan F, Li J, Yang C, Zhu B, Ye J, Cao S, Chong AS, Tan C, Si Y.   +15 more
europepmc   +1 more source

Impact of Bone Grafting and Graft Type on Fusion and Patient‐Reported Outcomes Following Subtalar Arthrodesis: A Multicenter Retrospective Cohort Study

Journal of Foot and Ankle Research, Volume 19, Issue 2, June 2026.
ABSTRACT Background The role of bone grafting in subtalar joint arthrodesis (SJA) remains controversial. This study aimed to compare clinical and radiographic outcomes of SJA performed with and without bone graft and to evaluate the influence of different graft types on fusion and functional results.
Giovan Giuseppe Mazzella, Antonio Bove, Andrea De Fazio, Natale Maria Gangemi, Marco Peruzzi, Fabrizio Forconi, Philip Krekosch, Christian Lausmann, Mustafa Citak, Vincenzo Di Sanzo, Giulio Maccauro, Raffaele Vitiello   +11 more
wiley   +1 more source

Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan Aburrá Valley, Colombia. [PDF]

Vaccines (Basel)
Hernández-Ortiz OH, Naranjo AF, Vélez-Cadavid JJ, De La Rosa G, Gil BA, Moreno AM, Perez-Restrepo LS, Usuga J, Aristizabal-Valencia M, Molina-Saldarriaga F, Sará-Ochoa JE, Betancourt-Rodriguez N, Jaimes F, Osorio JE, Hernández-Ortiz JP.   +14 more
europepmc   +1 more source

Broadly Protective Antibody‐Like Vaccines Against Highly Pathogenic Coronaviruses

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT SARS‐CoV‐2 and MERS‐CoV are highly pathogenic and contagious coronaviruses. Despite intensive vaccination, SARS‐CoV‐2 continues to spread, and no FDA‐approved vaccines exist for MERS‐CoV; thus, more effective and safer vaccine options are needed. The receptor‐binding domain (RBD) of coronaviruses is a primary target of neutralizing antibodies (
Assala Helal, Najwa D. Aljehani, Aishah Ghazwani, Reem M. Alsulaiman, Faris Alyami, Wesam H. Abdulaal, Asem Alsharef, Maimonah Alghanmi, Ayat Zawawi, Ala A. Azhari, Afnan Almehmadi, Jood Balula, Tarfa Altorki, Rowa Y. Alhabbab, Muhammad Yasir Khan, Khalid Alluhaybi, Aisha Alnami, Thikryat Neamatallah, Turki S. Abujamel, Mohamed A. Alfaleh, Anwar M. Hashem   +20 more
wiley   +1 more source

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2. [PDF]

Vaccines (Basel)
Tangsathapornpong A, Nanthapisal S, Fukpho W, Bunjoungmanee P, Neamkul Y, Pontan K, Boonyarangkul A, Wanpen S, Thongphubeth K, Tharabenjasin P, Jaru-Ampornpan P.   +10 more
europepmc   +1 more source

Booster mRNA Vaccination Prevents Breakthrough Severe COVID‐19 Infections

Journal of Medical Virology, Volume 98, Issue 6, June 2026.
ABSTRACT This study aimed to assess the humoral immune response following administration of a BNT162b2 mRNA COVID‐19 booster dose and to evaluate its association with the development of SARS‐CoV‐2 infection after vaccination. Between July 2021 and February 2022, serum samples were collected from 313 individuals 28 days after receiving a COVID‐19 ...
Harika Öykü Dinç, Hayriye Kirkoyun. Uysal, Günay Can, Beyhan Budak, Ferhat Osman Daşdemir, Elif Keskin, Okan Aydoğan, İlker İnanç Balkan, Rıdvan Karaali, Suat Saribaş, Sevgi Ergin, Neşe Saltoğlu, Bekir Kocazeybek   +12 more
wiley   +1 more source